Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system ... In a new study, researchers reviewed ...

In this difficult clinical situation ... rituximab? SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

Neuropsychiatric manifestations of systemic lupus erythematosus (SLE ... and current treatments rely on clinical experience. This Review covers recent clinical advances in this area and emphasizes ...

Panelists discuss the significant clinical and economic burdens ... How many patients have systemic lupus erythematosus (SLE)? How often do patients with SLE present with or develop LN?

Doctors in Hangzhou, Zhejiang province, have successfully completed the world's largest clinical study of involving the use ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...